Commercial Novo’s Wegovy pill reaches 1M patients, shattering expectations with $355M in sales BioSpaceAnalysts and investors alike had been eagerly awaiting sales figures for Novo Nordisk's Wegovy pill.Metabolic & GLP-1Read full story pharminent May 6, 2026 (Last updated: May 7, 2026) BioSpace Analysts and investors alike had been eagerly awaiting sales figures for Novo Nordisk’s Wegovy pill. Metabolic & GLP-1 Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: CellCentric secures $220M in Europe’s biggest private biotech fundraise of 2026Next: FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight Related Stories Commercial Wegovy pill launches in UK as first daily oral GLP1 for weight management pharminent July 6, 2026 Commercial Tryngolza charts blockbuster course after FDA’s hypertriglyceridemia approval pharminent June 26, 2026 Commercial Lilly launches its LillyDirect sales channel in the UK pharminent June 25, 2026
